FdaApplication
NDA 213593
Identifiers
- fda_app_no: NDA213593
Properties
| Property | Value |
|---|---|
| applicant_name | AZURITY PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2022-08-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KONVOMEP | OMEPRAZOLE; SODIUM BICARBONATE | 2MG/ML;84MG/ML | FOR SUSPENSION;ORAL |
1 product